triazavirin
Small moleculeexperimentalCOVID-19
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
1
Earliest trial started Sep 8, 2020 (NCT04581915)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Influenza A virusANTAGONIST
Influenza A virus antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04973462 | Phase 4 | Aug 1, 2021 | Ain Shams University |
| NCT04581915 | Phase 2/Phase 3 (Phase 3) | Sep 8, 2020 | PharmaCentrix, University of the Witwatersrand, Wits Health Consortium (Pty) Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| PharmaCentrix | For profit | 1 | 0 | 1 | 2020 |
| University of the Witwatersrand | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Wits Health Consortium (Pty) Ltd | Academic/Hospital | 1 | 1 | 1 | 2020 |
4 organizations
Page 1 / 1